MESALAMINE
| Brand name | SFROWASA |
|---|---|
| Active ingredient | MESALAMINE |
| Strength | 4GM/60ML |
| Dosage form | ENEMA |
| Route | RECTAL |
| Modality | Small molecule |
| FDA approval | June 2008 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 7645801 | July 2027 | substance, product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.